This inventor holds 16 USPTO granted patents and 17 published patent applications and 5 EPO patents. Top assignees: Gasherbrum Bio, Inc., Eli Lilly and Company, Lhotse Bio, Inc. Active years: 2019-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Indianapolis, IN (US) (2019)
- Shanghai, CN (2019 - 2024)
Company Filing History:
8 out of 9 
4 out of 4,509 
2 out of 2 Years Active: 2019-2026
Title: **Innovative Contributions of Inventor Haizhen Zhang**
Introduction
Haizhen Zhang, an accomplished inventor based in Shanghai, China, has made notable contributions to the field of pharmaceuticals. With a portfolio of 10 patents, his work primarily focuses on developing novel compounds that can advance therapeutic options for various medical conditions. His latest innovations highlight significant advances in drug design and formulation.
Latest Patents
Among his most recent patents are the Heterocyclic GLP-1 agonists. This disclosure relates to GLP-1 agonists of Formula (I), which include pharmaceutically acceptable salts and solvates thereof, as well as pharmaceutical compositions incorporating these compounds. The ingenuity behind these inventions signifies a potential leap in the management of conditions such as diabetes.
Career Highlights
Haizhen Zhang has built a robust career, contributing to research and development at renowned organizations. He has worked with Gasherbrum Bio, Inc. and Eli Lilly and Company, bringing innovative solutions to the pharmaceutical industry and showcasing his commitment to improving patient outcomes through scientific research.
Collaborations
Throughout his career, Haizhen has collaborated with esteemed colleagues, including Hui Lei and Qinghua Meng. These partnerships have been pivotal in fostering an environment of innovation and advancing the frontiers of pharmaceutical research. By working together, they have been able to combine their expertise to drive forward new discoveries in drug development.
Conclusion
Haizhen Zhang exemplifies the spirit of innovation in the pharmaceutical sector. His ten patents reflect a dedication to improving health outcomes through advanced research and collaboration. As he continues to contribute to this vital field, the impact of his inventions and partnerships will undoubtedly resonate in the healthcare landscape.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile